 |
|
|
| |
In vitro profiling of GSK2336805, A Potent and Selective Inhibitor of HCV NS5A
|
| |
| |
Reported by Jules Levin
EASL 2011 March 31-Apr 2 Berlin Germany
J. Bechtel1, R. Crosby1, A. Wang1, E. Woldu1, S. Van Horn2, J. Horton1, K. Remlinger1, K. Creech1, L.H. Carballo1, S. You1, C. Voitenleitner1, J. Vamathevan3, M. Duan1, A. Spaltenstein1, W. Kazmierski1, C. Roberts1and R. Hamatake1
1GlaxoSmithKline, Research Triangle Park, NC, USA; 2GlaxoSmithKline, Upper Providence, PA, USA, 3GlaxoSmithKline, Stevenage, UK
EASL International Liver Congress 2011, Berlin, Germany
|
| |
|
|
|
|
|
